Department of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA.
Angew Chem Int Ed Engl. 2010 Oct 18;49(43):7904-8. doi: 10.1002/anie.201004057.
Phase-change materials (PCMs), including 1-tetradecanol with a melting point at 38–39 °C and dodecanoic acid with a melting point at 43–46 °C were exploited as thermosensitive materials to demonstrate a new temperature-regulated drug release system. In this approach, colloidal particles containing FITC-dextran were embedded in the PCM matrix and processed as spheres or rods. When temperature was below the melting point of the PCM, there was no release of FITC-dextran due to the hydrophobic nature of the PCM. As the temperature was increased beyond the melting point, the PCM began to melt, the encapsulated particles leached out, and eventually FITC-dextran was released from the colloidal particles. By using colloidal particles made of gelatin, chitosan, and poly(lactic-co-glycolic acid) that have different solubility in water, we could manipulate the release pattern of FITC-dextran. We also demonstrated a dual temperature-regulated drug release system by incorporating two different PCMs into the same device. As an attractive feature, we could easily alter the initiation temperature and release pattern of drugs by judiciously selecting different combinations of PCMs and materials for the colloidal particles.
相变材料(PCM),包括熔点在 38-39°C 的十四醇和熔点在 43-46°C 的十二酸,被用作热敏材料,以展示新的温度调节药物释放系统。在这种方法中,含有 FITC-葡聚糖的胶体颗粒被嵌入 PCM 基质中,并加工成球体或棒体。当温度低于 PCM 的熔点时,由于 PCM 的疏水性,没有 FITC-葡聚糖的释放。随着温度升高超过 PCM 的熔点,PCM 开始熔化,包封的颗粒渗出,最终 FITC-葡聚糖从胶体颗粒中释放出来。通过使用在水中具有不同溶解度的明胶、壳聚糖和聚(乳酸-共-乙醇酸)制成的胶体颗粒,我们可以控制 FITC-葡聚糖的释放模式。我们还通过将两种不同的 PCM 纳入同一装置来展示双温度调节药物释放系统。作为一个吸引人的特点,我们可以通过明智地选择不同的 PCM 组合和胶体颗粒材料来轻松改变药物的起始温度和释放模式。